Montag & Caldwell LLC Increases Holdings in Sherwin-Williams Co (SHW)

Montag & Caldwell LLC raised its position in Sherwin-Williams Co (NYSE:SHW) by 7.2% in the second quarter, according to its most recent disclosure with the SEC. The firm owned 176,834 shares of the specialty chemicals company’s stock after acquiring an additional 11,885 shares during the period. Sherwin-Williams makes up about 2.9% of Montag & Caldwell LLC’s holdings, making the stock its 19th largest position. Montag & Caldwell LLC owned 0.19% of Sherwin-Williams worth $72,073,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in the business. BlackRock Inc. grew its stake in Sherwin-Williams by 0.9% in the first quarter. BlackRock Inc. now owns 5,633,466 shares of the specialty chemicals company’s stock valued at $2,208,994,000 after acquiring an additional 47,494 shares during the period. Massachusetts Financial Services Co. MA grew its stake in Sherwin-Williams by 2.7% in the second quarter. Massachusetts Financial Services Co. MA now owns 3,965,703 shares of the specialty chemicals company’s stock valued at $1,616,302,000 after acquiring an additional 103,497 shares during the period. JPMorgan Chase & Co. grew its stake in Sherwin-Williams by 4.4% in the first quarter. JPMorgan Chase & Co. now owns 1,396,160 shares of the specialty chemicals company’s stock valued at $547,463,000 after acquiring an additional 58,419 shares during the period. Fiera Capital Corp grew its stake in Sherwin-Williams by 3.3% in the first quarter. Fiera Capital Corp now owns 1,311,131 shares of the specialty chemicals company’s stock valued at $514,120,000 after acquiring an additional 42,234 shares during the period. Finally, Principal Financial Group Inc. grew its stake in Sherwin-Williams by 5.8% in the first quarter. Principal Financial Group Inc. now owns 1,118,210 shares of the specialty chemicals company’s stock valued at $438,474,000 after acquiring an additional 61,587 shares during the period. 74.89% of the stock is owned by hedge funds and other institutional investors.

Get Sherwin-Williams alerts:

A number of brokerages have commented on SHW. Jefferies Financial Group reissued a “hold” rating and issued a $465.00 price objective on shares of Sherwin-Williams in a research note on Wednesday, July 25th. Northcoast Research reissued a “buy” rating and issued a $465.00 price objective on shares of Sherwin-Williams in a research note on Friday, July 27th. Credit Suisse Group set a $457.00 price objective on Sherwin-Williams and gave the company a “buy” rating in a research note on Wednesday, May 23rd. Morgan Stanley raised their price objective on Sherwin-Williams from $425.00 to $455.00 and gave the company an “overweight” rating in a research note on Tuesday, July 17th. Finally, Zacks Investment Research cut Sherwin-Williams from a “buy” rating to a “hold” rating in a research report on Wednesday, April 4th. One research analyst has rated the stock with a sell rating, seven have issued a hold rating, sixteen have issued a buy rating and one has assigned a strong buy rating to the company. The company has an average rating of “Buy” and an average price target of $461.60.

In related news, insider Joel D. Baxter sold 2,533 shares of Sherwin-Williams stock in a transaction on Friday, July 27th. The stock was sold at an average price of $447.21, for a total transaction of $1,132,782.93. Following the sale, the insider now directly owns 1,593 shares in the company, valued at $712,405.53. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Susan J. Kropf sold 995 shares of Sherwin-Williams stock in a transaction on Thursday, July 26th. The stock was sold at an average price of $445.43, for a total value of $443,202.85. The disclosure for this sale can be found here. Insiders have sold 24,474 shares of company stock worth $10,777,564 over the last quarter. 0.78% of the stock is currently owned by corporate insiders.

Shares of Sherwin-Williams traded down $0.52, hitting $437.73, during mid-day trading on Thursday, MarketBeat Ratings reports. 4,093 shares of the company traded hands, compared to its average volume of 648,666. The stock has a market cap of $41.16 billion, a price-to-earnings ratio of 30.71, a PEG ratio of 1.92 and a beta of 1.22. The company has a quick ratio of 0.75, a current ratio of 1.20 and a debt-to-equity ratio of 2.59. Sherwin-Williams Co has a 12-month low of $326.68 and a 12-month high of $450.83.

Sherwin-Williams (NYSE:SHW) last announced its earnings results on Tuesday, July 24th. The specialty chemicals company reported $5.73 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $5.59 by $0.14. The company had revenue of $4.77 billion for the quarter, compared to analysts’ expectations of $4.65 billion. Sherwin-Williams had a return on equity of 46.68% and a net margin of 10.84%. Sherwin-Williams’s quarterly revenue was up 27.8% on a year-over-year basis. During the same quarter in the previous year, the firm earned $4.52 earnings per share. equities research analysts expect that Sherwin-Williams Co will post 19.27 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, September 7th. Investors of record on Friday, August 17th will be issued a dividend of $0.86 per share. The ex-dividend date is Thursday, August 16th. This represents a $3.44 dividend on an annualized basis and a yield of 0.79%. Sherwin-Williams’s dividend payout ratio (DPR) is currently 24.11%.

Sherwin-Williams Company Profile

The Sherwin-Williams Company develops, manufactures, distributes, and sells paints, coatings, and related products to professional, industrial, commercial, and retail customers primarily in North and South America, the Caribbean, Europe, Asia, and Australia. The company operates in three segments: The Americas Group, Consumer Brands Group, and Performance Coatings Group.

See Also: Book Value Per Share �� BVPS

Top Small Cap Stocks To Buy Right Now

tags:CNR,FCEL,PQ,ACHN,

On Thursday, our Elite Opportunity Pro�newsletter suggested�small cap embedded antenna technologies stock Airgain Inc (NASDAQ: AIRG) as a buy:

��Fundamentally, AIRG is a classic growth play�� Basically, what's not to like about AIRG from a fundamental perspective? Well, nothing really, but from a purely technical perspective, AIRG has not been for the faint of heart. Following its initial IPO back in September of last year, the stock went on a tear before inevitably falling apart later in the year��.��

����This is not a short-term play, but rather an idea you may want to allocate what you're willing to risk, and simply sit on it. Small caps clearly can be tremendously rewarding or extremely frustrating, however, we do believe when it's all said and done, AIRG has all of the makings of a nice little home-run someday.��

Top Small Cap Stocks To Buy Right Now: China Metro-Rural Holdings Limited(CNR)

Advisors' Opinion:

• [By Shane Hupp]

  Wall Street analysts expect that Canadian National Railway (NYSE:CNI) (TSE:CNR) will announce $1.02 earnings per share (EPS) for the current quarter, according to Zacks Investment Research. Seven analysts have provided estimates for Canadian National Railway’s earnings, with the highest EPS estimate coming in at $1.06 and the lowest estimate coming in at $0.97. Canadian National Railway reported earnings per share of $1.00 in the same quarter last year, which would suggest a positive year over year growth rate of 2%. The company is expected to announce its next quarterly earnings results on Tuesday, July 24th.

• [By Stephan Byrd]

  Brokerages expect Canadian National Railway (NYSE:CNI) (TSE:CNR) to announce earnings of $1.03 per share for the current fiscal quarter, Zacks Investment Research reports. Eight analysts have issued estimates for Canadian National Railway’s earnings, with the highest EPS estimate coming in at $1.10 and the lowest estimate coming in at $0.97. Canadian National Railway reported earnings of $1.00 per share in the same quarter last year, which would indicate a positive year over year growth rate of 3%. The business is scheduled to issue its next quarterly earnings report on Tuesday, July 24th.

• [By Joseph Griffin]

  Shares of Canadian National Railway (TSE:CNR) (NYSE:CNI) have been given an average recommendation of “Buy” by the eleven research firms that are covering the firm, MarketBeat reports. One investment analyst has rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average 12-month price target among brokerages that have updated their coverage on the stock in the last year is C$109.36.

• [By Shane Hupp]

  Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp cut its position in Canadian National Railway (NYSE:CNI) (TSE:CNR) by 21.1% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,956,400 shares of the transportation company’s stock after selling 522,300 shares during the period. Canadian National Railway accounts for about 1.7% of Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp’s investment portfolio, making the stock its 7th biggest position. Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp owned 0.27% of Canadian National Railway worth $184,215,000 at the end of the most recent reporting period.

• [By Max Byerly]

  Canadian National Railway (NYSE:CNI) (TSE:CNR) – Cormark raised their Q3 2018 earnings per share (EPS) estimates for Canadian National Railway in a research report issued to clients and investors on Tuesday, April 10th. Cormark analyst D. Tyerman now expects that the transportation company will post earnings per share of $1.15 for the quarter, up from their previous estimate of $1.14.

• [By Max Byerly]

  Compass Capital Management Inc. bought a new position in Canadian National Railway (NYSE:CNI) (TSE:CNR) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 2,535 shares of the transportation company’s stock, valued at approximately $207,000.

Top Small Cap Stocks To Buy Right Now: FuelCell Energy Inc.(FCEL)

Advisors' Opinion:

• [By Logan Wallace]

  FuelCell Energy (NASDAQ: FCEL) and HRG Group (NYSE:HRG) are both oils/energy companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, valuation, risk, analyst recommendations, institutional ownership, earnings and profitability.

• [By Joseph Griffin]

  Get a free copy of the Zacks research report on FuelCell Energy (FCEL)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Paul Ausick]

  FuelCell Energy Inc. (NASDAQ: FCEL) posted an increase of 43.9% in short interest during the period. Some 10.68 million shares were short as of June 29. The stock closed most recently at $1.33, down about 1.5% for the day, in a 52-week range of $1.29 to $2.49. Shares traded down more than 20% in the short interest period, and days to cover dropped from six to four.

• [By Paul Ausick]

  FuelCell Energy Inc. (NASDAQ: FCEL) posted a decrease of 4% in short interest during the period. Some 7.42 million shares were short as of June 15. The stock closed at $1.37 on Tuesday, down about 1.4% for the day, in a 52-week range of $1.18 to $2.49. Shares traded down more than 10% in the short interest period, and days to cover dropped from 17 to six.

Top Small Cap Stocks To Buy Right Now: Petroquest Energy Inc(PQ)

Advisors' Opinion:

• [By Ethan Ryder]

  News headlines about Petroquest Energy (NYSE:PQ) have been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern identifies negative and positive news coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Petroquest Energy earned a coverage optimism score of 0.05 on Accern’s scale. Accern also gave news stories about the energy company an impact score of 47.638327846877 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

Top Small Cap Stocks To Buy Right Now: Achillion Pharmaceuticals Inc.(ACHN)

Advisors' Opinion:

• [By Joseph Griffin]

  Get a free copy of the Zacks research report on Achillion Pharmaceuticals (ACHN)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Keith Speights]

  Skeptics might deride a comparison of Inovio Pharmaceuticals, Inc. (NASDAQ:INO) and Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) as an exercise in finding the biggest loser. Both companies continue to post huge net losses every quarter, and their stocks are down by at least 30% over the last 12 months.

• [By Ethan Ryder]

  Achillion Pharmaceuticals (NASDAQ:ACHN) – Research analysts at B. Riley reduced their FY2018 EPS estimates for shares of Achillion Pharmaceuticals in a research note issued to investors on Wednesday, May 2nd. B. Riley analyst M. Kumar now anticipates that the biopharmaceutical company will earn ($0.58) per share for the year, down from their previous estimate of ($0.55). B. Riley has a “Neutral” rating and a $3.50 price objective on the stock. B. Riley also issued estimates for Achillion Pharmaceuticals’ FY2019 earnings at ($0.64) EPS, FY2020 earnings at ($0.71) EPS, FY2021 earnings at ($0.70) EPS and FY2022 earnings at ($0.84) EPS.

• [By Stephan Byrd]

  Get a free copy of the Zacks research report on Achillion Pharmaceuticals (ACHN)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Shane Hupp]

  News articles about Achillion Pharmaceuticals (NASDAQ:ACHN) have trended somewhat positive this week, Accern Sentiment reports. The research firm ranks the sentiment of press coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Achillion Pharmaceuticals earned a media sentiment score of 0.16 on Accern’s scale. Accern also gave news articles about the biopharmaceutical company an impact score of 46.941587509483 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.